Haisco Pharmaceutical Group Co., Ltd. (002653.SZ)
CNY 35.95
(6.99%)
CNY 35.95
(6.99%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 281.29 Million CNY | -18.7% |
| 2022 | 345.99 Million CNY | 33.1% |
| 2021 | 259.94 Million CNY | 16.1% |
| 2020 | 223.9 Million CNY | 18.31% |
| 2019 | 189.25 Million CNY | 27.28% |
| 2018 | 148.68 Million CNY | 1.7% |
| 2017 | 146.19 Million CNY | 20.68% |
| 2016 | 121.14 Million CNY | 53.79% |
| 2015 | 78.77 Million CNY | 14.11% |
| 2014 | 69.03 Million CNY | 5.89% |
| 2013 | 65.19 Million CNY | 98.71% |
| 2012 | 32.8 Million CNY | 17.11% |
| 2011 | 28.01 Million CNY | 35.55% |
| 2010 | 20.66 Million CNY | -47.26% |
| 2009 | 39.18 Million CNY | 163.75% |
| 2008 | 14.85 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 286.02 Million CNY | 4.79% |
| 2024 Q1 | 278.72 Million CNY | -0.91% |
| 2024 Q2 | 272.95 Million CNY | -2.07% |
| 2023 Q1 | 376.29 Million CNY | 8.76% |
| 2023 FY | 281.29 Million CNY | -18.7% |
| 2023 Q4 | 281.29 Million CNY | -8.04% |
| 2023 Q3 | 305.88 Million CNY | -14.7% |
| 2023 Q2 | 358.58 Million CNY | -4.71% |
| 2022 FY | 345.99 Million CNY | 33.1% |
| 2022 Q4 | 345.99 Million CNY | 7.1% |
| 2022 Q3 | 323.07 Million CNY | -3.37% |
| 2022 Q2 | 334.32 Million CNY | 13.9% |
| 2022 Q1 | 293.52 Million CNY | 12.92% |
| 2021 Q3 | 248.76 Million CNY | 11.19% |
| 2021 Q2 | 223.73 Million CNY | -7.3% |
| 2021 FY | 259.94 Million CNY | 16.1% |
| 2021 Q1 | 241.35 Million CNY | 7.8% |
| 2021 Q4 | 259.94 Million CNY | 4.5% |
| 2020 Q1 | 214.76 Million CNY | 13.48% |
| 2020 Q2 | 242.21 Million CNY | 12.78% |
| 2020 Q3 | 234.91 Million CNY | -3.02% |
| 2020 Q4 | 223.9 Million CNY | -4.69% |
| 2020 FY | 223.9 Million CNY | 18.31% |
| 2019 Q1 | 142.05 Million CNY | -4.46% |
| 2019 Q3 | 169.72 Million CNY | 13.67% |
| 2019 Q4 | 189.25 Million CNY | 11.51% |
| 2019 FY | 189.25 Million CNY | 27.28% |
| 2019 Q2 | 149.31 Million CNY | 5.1% |
| 2018 FY | 148.68 Million CNY | 1.7% |
| 2018 Q1 | 138.35 Million CNY | -5.36% |
| 2018 Q2 | 139.24 Million CNY | 0.64% |
| 2018 Q3 | 143.96 Million CNY | 3.39% |
| 2018 Q4 | 148.68 Million CNY | 3.28% |
| 2017 Q4 | 146.19 Million CNY | 7.02% |
| 2017 FY | 146.19 Million CNY | 20.68% |
| 2017 Q3 | 136.6 Million CNY | 4.08% |
| 2017 Q2 | 131.25 Million CNY | -9.06% |
| 2017 Q1 | 144.32 Million CNY | 19.13% |
| 2016 Q2 | 82.2 Million CNY | -8.56% |
| 2016 FY | 121.14 Million CNY | 53.79% |
| 2016 Q1 | 89.89 Million CNY | 14.12% |
| 2016 Q4 | 121.14 Million CNY | 14.41% |
| 2016 Q3 | 105.88 Million CNY | 28.81% |
| 2015 Q2 | 74.77 Million CNY | -6.42% |
| 2015 FY | 78.77 Million CNY | 14.11% |
| 2015 Q4 | 78.77 Million CNY | -2.18% |
| 2015 Q3 | 80.53 Million CNY | 7.7% |
| 2015 Q1 | 79.9 Million CNY | 15.75% |
| 2014 FY | 69.03 Million CNY | 5.89% |
| 2014 Q3 | 66.96 Million CNY | -0.5% |
| 2014 Q2 | 67.29 Million CNY | 2.1% |
| 2014 Q1 | 65.91 Million CNY | 1.11% |
| 2014 Q4 | 69.03 Million CNY | 3.09% |
| 2013 Q3 | 64.03 Million CNY | 20.33% |
| 2013 FY | 65.19 Million CNY | 98.71% |
| 2013 Q4 | 65.19 Million CNY | 1.8% |
| 2013 Q1 | 43 Million CNY | 31.09% |
| 2013 Q2 | 53.21 Million CNY | 23.74% |
| 2012 Q2 | 26.33 Million CNY | -1.17% |
| 2012 Q3 | 27.98 Million CNY | 6.29% |
| 2012 Q4 | 32.8 Million CNY | 17.23% |
| 2012 FY | 32.8 Million CNY | 17.11% |
| 2012 Q1 | 26.64 Million CNY | -4.89% |
| 2011 FY | 28.01 Million CNY | 35.55% |
| 2011 Q2 | 23.48 Million CNY | 0.0% |
| 2011 Q3 | 23.85 Million CNY | 1.61% |
| 2011 Q4 | 28.01 Million CNY | 17.41% |
| 2010 FY | 20.66 Million CNY | -47.26% |
| 2010 Q4 | 20.66 Million CNY | 0.0% |
| 2009 FY | 39.18 Million CNY | 163.75% |
| 2008 FY | 14.85 Million CNY | 0.0% |